Health and productivity burden of coronary heart disease in the working Indonesian population using life-table modelling.
coronary heart disease
health economics
preventive medicine
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
09 09 2020
09 09 2020
Historique:
entrez:
11
9
2020
pubmed:
12
9
2020
medline:
15
5
2021
Statut:
epublish
Résumé
The impact of coronary heart disease (CHD) and its effect on work productivity at a population level remains unknown in Indonesia. This study estimates the health and productivity lost to CHD in terms of years of life, quality-adjusted life years (QALYs) and productivity-adjusted life years (PALYs). A life-table model was constructed to simulate the experiences of Indonesians currently aged 15-54 years (working age) with CHD, followed-up to 55 years (retirement age). The life-table analysis was then repeated assuming that the cohort did not have CHD. Differences in the results reflected the impact of CHD. Demographical, prevalence and mortality data were based on the 2017 Global Burden of Disease study and 2018 Indonesian National Health Survey. Costs, productivity indices and utilities were derived from published sources. The cost of each PALY was assumed to be equivalent to gross domestic product per equivalent full-time worker (US$11 765). Future costs and outcomes were discounted by 3% annually. Differences in total deaths, years of life and PALYs represented the impact of CHD. At present, 1 954 543 (1.45%) Indonesians of working-age have CHD. By retirement age, it was estimated that CHD resulted in 32 492 (36.6%) excess deaths, 128 132 (0.5%) years of life lost, 2 331 495 (10.5%) QALYs lost and 1 589 490 (6.9%) PALYs lost. The economic impact of lost productivity amounted to US$33.3 billion, and healthcare costs to US$139 billion. The health and economic burden of CHD in Indonesia looms large. This highlights the importance of its prevention and control, strategies for which, if effective, will deliver financial return.
Identifiants
pubmed: 32912956
pii: bmjopen-2020-039221
doi: 10.1136/bmjopen-2020-039221
pmc: PMC7482464
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e039221Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Appl Health Econ Health Policy. 2020 Aug;18(4):579-587
pubmed: 32009211
Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157
pubmed: 30955367
Diabetologia. 2010 Aug;53(8):1612-9
pubmed: 20454950
Can J Cardiol. 2009 Jun;25(6):e195-202
pubmed: 19536390
Heart. 2002 Dec;88(6):597-603
pubmed: 12433888
J Occup Environ Med. 2004 Apr;46(4):398-412
pubmed: 15076658
Int J Cardiol. 2016 Dec 1;224:256-264
pubmed: 27664572
BMC Public Health. 2019 Jun 21;19(1):802
pubmed: 31226965
BMC Health Serv Res. 2015 Jun 25;15:245
pubmed: 26104784
BMC Public Health. 2018 Aug 6;18(1):975
pubmed: 30081871
Tob Control. 2020 Jan;29(1):111-117
pubmed: 30610080
Biomed Res Int. 2018 Sep 26;2018:2643814
pubmed: 30356405
PLoS One. 2018 May 11;13(5):e0197098
pubmed: 29750806
Tob Control. 2019 May;28(3):297-304
pubmed: 30012640
J Occup Health Psychol. 2011 Oct;16(4):483-500
pubmed: 21875212